The availability of ABPs allowing sensitive detection of GBA in leukocytes prompted us to study the fate of the enzyme in LIMP2-deficient cells, obtained from an AMRF patient as well as from LIMP2-deficient mice. Here, SCARB2 is linked to action myoclonus-renal failure syndrome.